Skip to main content
. 2014 Aug 6;18(8):1519–1539. doi: 10.1111/jcmm.12278

Fig. 4.

Fig. 4

Funnel plots by using PFS/TTP as an outcome for (A) single-agent erlotinib (B) single-agent gefitinib and (C) chemotherapy in the first-line setting. PFS: progression-free survival; TTP: time to progression; CI: confidence interval.